subcutaneous
Showing 1 - 25 of >10,000
Surgical Site Infection Trial (Subcutaneous drain, No drain)
Not yet recruiting
- Surgical Site Infection
- Subcutaneous drain
- No drain
- (no location specified)
Sep 29, 2023
Nursing Education Trial in Istanbul (subcutaneous injection administration game, control group)
Completed
- Nursing Education
- subcutaneous injection administration game
- control group
-
Istanbul, TurkeyBurcu Demircan
Sep 7, 2023
Epilepsy Trial in London (EEG SubQ subcutaneous EEG device)
Recruiting
- Epilepsy
- EEG SubQ subcutaneous EEG device
-
London, United KingdomKing's College London
Nov 20, 2023
IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- (no location specified)
Oct 27, 2023
Scleroderma, Systemic, Fibrosis, Semaglutide Trial (Semaglutide Pen Injector)
Not yet recruiting
- Scleroderma, Systemic
- +2 more
- Semaglutide Pen Injector
- (no location specified)
Nov 20, 2023
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Misadventure During Injection / Vaccination Trial in Kirklareli (stress ball use during subcutaneous injection)
Recruiting
- Misadventure During Injection / Vaccination
- stress ball use during subcutaneous injection
-
Kırklareli, TurkeyKırklareli University
Sep 2, 2023
Lipedema Trial (Diathermy, Placebo)
Not yet recruiting
- Lipedema
- Diathermy
- Placebo
- (no location specified)
Jul 12, 2023
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- No Intervention
- (no location specified)
Nov 21, 2023
Antineutrophil Cytoplasmic Antibody Associated Vasculitis Trial in Overland Park (STSA-1002 subcutaneous injection)
Recruiting
- Antineutrophil Cytoplasmic Antibody Associated Vasculitis
- STSA-1002 subcutaneous injection
-
Overland Park, KansasAltaSciences Clinical Kansas, Inc
Feb 2, 2023
Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin
Recruiting
- Myasthenia Gravis
- subcutaneous immunoglobulin (SCIG)
- intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 21, 2022
Overweight or Obese Women, Elective Lower Segment Cesarean Section Trial (continuous subcutaneous tissue closure, Interrupted
Not yet recruiting
- Overweight or Obese Women, Elective Lower Segment Cesarean Section
- continuous subcutaneous tissue closure
- Interrupted subcutaneous tissue closure
- (no location specified)
May 3, 2023
Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)
Not yet recruiting
- Type2diabetes
- Henagliflozin
- Continuous Subcutaneous Insulin Infusion
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Jan 9, 2023
Subcutaneous Fat Trial (CBL-514 Injection, 0.9% Sodium Chloride)
Not yet recruiting
- Subcutaneous Fat
- CBL-514 Injection
- 0.9% Sodium Chloride
- (no location specified)
Feb 19, 2023
Subcutaneous Fat Trial in Omaha (CBL-514 injection, CBL-A1 Injection, CBL-A2 Injection)
Not yet recruiting
- Subcutaneous Fat
- CBL-514 injection
- +3 more
-
Omaha, NebraskaInvestigational Site 1
Aug 17, 2023
Hemiplegic Shoulder Pain Trial in Taichung (Fu's subcutaneous needling (FSN), Rehabilitation)
Recruiting
- Hemiplegic Shoulder Pain
- Fu's subcutaneous needling (FSN)
- Rehabilitation
-
Taichung, TaiwanChina Medical University Hospital
Dec 7, 2022
Healthy Men Trial in Hefei (BAT1806 prefilled subcutaneous injection/RoActemra® (from EU))
Not yet recruiting
- Healthy Men
- BAT1806 prefilled subcutaneous injection/RoActemra® (from EU)
-
Hefei, Anhui, ChinaThe Second Affiliated Hospital of Anhui Medical University
Jul 27, 2023
Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin
Not yet recruiting
- Type 1 Diabetes Mellitus
- +2 more
- Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
-
Winston-Salem, North CarolinaWakeForest University Health Sciences
May 11, 2023
Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)
Recruiting
- Inflammatory Disease
- +2 more
- Infliximab subcutaneous
- Immunosuppressive Agents
-
Amsterdam, North Holland, NetherlandsAmsterdam UMC AMC
Sep 27, 2023
Patients With Septic Shock Trial in Dijon, Lyon (Subcutaneous pressure measurement)
Completed
- Patients With Septic Shock
- Subcutaneous pressure measurement
-
Dijon, France
- +1 more
Nov 29, 2022
Subcutaneous Injection Trial in Ankara (Group 1, Group 2, Group 3)
Active, not recruiting
- Subcutaneous Injection
- Group 1
- +2 more
-
Ankara, Çubuk, TurkeyAnkara Yildirim Beyazit University Faculty of Health Sciences, D
Apr 16, 2023
Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety
Recruiting
- Primary Immunodeficiency Diseases (PID)
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Aug 8, 2023
Ngenla Subcutaneous Injection Special Investigation
Not yet recruiting
- Growth Hormone Deficiency Without Epiphyseal Closure
- NGENLA (Somatrogon)
- (no location specified)
Dec 7, 2022
Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))
Not yet recruiting
- Atrial Fibrillation
- Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 6, 2023